Y chromosome microchimerism in Sjögren's syndrome
Open Access
- 1 November 2001
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (11) , 1078-1079
- https://doi.org/10.1136/ard.60.11.1078
Abstract
There are many similarities between graft versus host disease (GVHD) and some rheumatic autoimmune diseases, such as systemic sclerosis (SSc), Sjögren's syndrome (SS), and primary biliary cirrhosis. Bianchi et al reported that fetal cells could survive in the maternal circulation for up to 27 years after parturition. This phenomenon is called fetal microchimerism.1 Some observations led the hypothesis that persistent fetal cells in the maternal circulation could mediate a graft versus host reaction, resulting in autoimmune disease. It is known that during a chronic GVHD, a Sjögren-like syndrome, is often observed: a salivary gland biopsy sample from patients with chronic GVHD showed lymphocytic infiltration, similar to that found in SS.2 Nlson and colleagues have studied male fetal microchimerism in skin lesions …Keywords
This publication has 10 references indexed in Scilit:
- Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndromeAnnals of the Rheumatic Diseases, 2001
- Y chromosome microchimerism in rheumatic autoimmune diseaseAnnals of the Rheumatic Diseases, 2000
- Histopathological study of the human submandibular gland in graft versus host diseaseJournal of Clinical Pathology, 1999
- Long-Term Fetal Microchimerism in Peripheral Blood Mononuclear Cell Subsets in Healthy Women and Women With SclerodermaBlood, 1999
- Microchimerism and HLA-compatible relationships of pregnancy in sclerodermaThe Lancet, 1998
- Additional primer sets for an amelogenin gene PCR-based DNA-sex testInternational journal of legal medicine, 1997
- Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proceedings of the National Academy of Sciences, 1996
- Forensic application of a rapid and quantitative DNA sex test by amplification of the X-Y homologous gene amelogeninInternational journal of legal medicine, 1994
- Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European communityArthritis & Rheumatism, 1993